Acumen Pharmaceuticals, Inc.

NASDAQ:ABOS

1.2 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -28.796-37.154-29.765-20.537-14.873-16.497-12.957-11.61-11.307-12.866-10.71-10.151-9.129-8.349-3.902-61.358-26.997-0.755-2.49-2.035-2.045
Depreciation & Amortization 0.0450.0440.0450.0450.0440.0390.040.0530.0520.0490.0440.0390.0370.0030.001000000
Deferred Income Tax 00000000000000.1340000000
Stock Based Compensation 2.4742.3432.3382.472.4841.6341.61.5211.390.8880.840.7150.6180.3650.3040.1270.1260.0380.0390.0380.039
Change In Working Capital -7.3628.2213.7343.765-4.0676.054-0.878-1.3340.0240.8140.4522.761-0.0414.072-4.085-0.9731.284-1.5541.1680.5030.19
Accounts Receivables 000000000000000000.108-0.2170.256-0.226
Change In Inventory 000000000000000000000
Change In Accounts Payables -4.5923.306-1.861.1231.70.017-0.6621.262-0.878-0.4440.4160.4590.1210.706-0.890.3540.387-0.9230.8510.2270.153
Other Working Capital -2.774.9155.5942.642-5.7676.037-0.216-2.5960.9021.2580.0362.302-0.1623.366-3.195-1.3270.897-0.6310.3170.2760.037
Other Non Cash Items -0.482-0.669-0.948-2.288-1.4470.456-0.71-0.3-0.334-0.0880.1910.1680.2160.136-0.00557.9423.217-0.5860.8510.2260.153
Operating Cash Flow -34.121-27.215-24.596-16.545-17.859-8.314-12.905-11.67-10.175-11.203-9.183-6.468-8.299-3.639-7.688-4.264-2.37-2.857-1.283-1.494-1.816
Investing Activities:
Investments In Property Plant And Equipment -0.07900-0.005-0.011-0.014-0.00700-0.035-0.081-0.036-0.009-0.026-0.008-0.00600000
Acquisitions Net 0000000.003000.020-0.0090-94.0950000000
Purchases Of Investments -35.048-15.1-98.538-11.801-45.292-71.777-126.7260-52.131-29.3850-3.039-9.09-9.985-94.095000000
Sales Maturities Of Investments 63.81644.76388.40649.50536.122.98434.72911.06410.20495611.864-104.080000000
Other Investing Activites 0000-9.192-48.79300-0.042-0.020.0560.009-5.09198.175-94.095000000
Investing Cash Flow 28.68929.663-10.13237.699-9.203-48.807-92.00111.064-41.927-20.4255.9198.785-5.099-10.011-94.103-0.00600000
Financing Activities:
Debt Repayment 0-0.73900-0.7390000000000000000
Common Stock Issued 0-0.060.188-0.1287.938-0.39122.294-0.14503.792-0.263-0.0140-0.003168.78131.67500000
Common Stock Repurchased -0.073-0.00900-0.0320000000000000000
Dividends Paid 000000000000000000000
Other Financing Activities 0.0370.739-0.042-0.128-0.0629.5240.47-0.14500.392-0.263-0.01400.013168.78131.675044.675000
Financing Cash Flow -0.036-0.009-0.042-0.1287.10729.134122.764-0.14504.184-0.263-0.01400.01168.78131.675044.675000
Other Information:
Effect Of Forex Changes On Cash 00000000000000.0060000000
Net Change In Cash -5.4682.439-34.53521.026-19.955-27.98717.858-0.751-52.102-27.43946.4732.303-13.398-13.6466.9927.405-2.3741.818-1.283-1.494-1.816
Cash At End Of Period 30.39135.85933.4267.95546.9367.11995.10677.24877.999130.101157.54111.067108.764122.162135.80268.81241.40743.7771.9593.2424.736